Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Rent the Runway Inc (RENT) Price & Performance

Cassava Sciences IncTrade
Rent the Runway IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Rent the Runway Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Rent the Runway Inc trades at $3.32 (market cap $111.69M). The key difference: Rent the Runway Inc is far larger — about 2.1× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.

FLNARENT
Market Cap
$53.14M$111.69M
Sector
HealthConsumer Cyclical
52-Week High
$4.64$9.39
52-Week Low
$1.09$3.10
Enterprise Value
-$33.43M$271.79M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Rent the Runway Inc

RENT stock trades at $3.24, down 2.99% on the day, with a bearish technical signal. The company reported Q1 2026 revenue growth of 29% year-over-year to $89.9 million, beating EPS expectations, but maintains negative net income and free cash flow. Leadership is in transition with a new interim CEO. The balance sheet shows negative shareholder equity of -$182.5 million and high debt levels, though the debt-to-asset ratio is projected to improve significantly by 2026.

The outlook is mixed: low valuation multiples (P/S 0.18) suggest potential upside, but persistent losses, high debt, and leadership changes pose significant risks. Analyst consensus is cautious with 42% buy ratings. Revenue growth and balance sheet improvements are key to watch, but the stock carries high risk due to profitability challenges.

Returns comparison

Trailing returns across standard periods

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Rent the Runway Inc

Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.

Read more on RENT